SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-18-008500
Filing Date
2018-06-29
Accepted
2018-06-29 14:06:13
Documents
42
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0318_taxuspharmaceutic.htm 10-Q 306376
2 CERTIFICATION f10q0318ex31-1_taxuspharm.htm EX-31.1 14752
3 CERTIFICATION f10q0318ex31-2_taxuspharm.htm EX-31.2 14120
4 CERTIFICATION f10q0318ex32-1_taxuspharm.htm EX-32.1 7734
5 CERTIFICATION f10q0318ex32-2_taxuspharm.htm EX-32.2 9422
  Complete submission text file 0001213900-18-008500.txt   1304963

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE tax-20180331.xml EX-101.INS 175947
7 XBRL SCHEMA FILE tax-20180331.xsd EX-101.SCH 14918
8 XBRL CALCULATION FILE tax-20180331_cal.xml EX-101.CAL 25324
9 XBRL DEFINITION FILE tax-20180331_def.xml EX-101.DEF 21852
10 XBRL LABEL FILE tax-20180331_lab.xml EX-101.LAB 96900
11 XBRL PRESENTATION FILE tax-20180331_pre.xml EX-101.PRE 76480
Mailing Address 245-16 HORACE HARDING EXPRESSWAY, LITTLE NECK NY 11362
Business Address 245-16 HORACE HARDING EXPRESSWAY, LITTLE NECK NY 11362 7186311522
TAXUS PHARMACEUTICALS HOLDINGS, INC. (Filer) CIK: 0001622676 (see all company filings)

IRS No.: 030380057 | State of Incorp.: NY | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 333-200602 | Film No.: 18928681
SIC: 5912 Retail-Drug Stores and Proprietary Stores
Assistant Director 9